RecruitingNot Applicable

Cauterization Versus ﬁbrin Glue for Conjunctival Autografting in Primary Pterygium Surgery

Croatia164 participantsStarted 2018-05-08

Plain-language summary

Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motility, chronic inflammation and cosmetic concerns. Surgical removal is the treatment of choice, but recurrence of pterygium is a frequent problem. In this randomized controlled cauterization will be compared with ﬁbrin glue for conjunctival autografting in primary pterygium surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * adults (older than 18 years of age) * both sexes * primary nasal pterygia ˃4 mm, which tends to increase, including patients with reduced visual acuity, chronic inflammation, cosmetic reasons * if the patients had a bilateral pterygium, only one eye will be operated Exclusion criteria: * connective tissue disease * prior eye surgery * chronic use of topical drugs (anti-glaucoma drugs)

What they're measuring

Recurrence of pterygium

Timeframe: 180 days

Trial details

NCT IDNCT03321201

SponsorUniversity of Split, School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-01

View on ClinicalTrials.gov More Pterygium of Conjunctiva and Cornea trials